Linscomb Wealth Inc. Increases Stock Position in Waters Co. (NYSE:WAT)

Linscomb Wealth Inc. raised its stake in Waters Co. (NYSE:WAT) by 2.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,032 shares of the medical instruments supplier’s stock after acquiring an additional 191 shares during the quarter. Linscomb Wealth Inc.’s holdings in Waters were worth $2,891,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Kennebec Savings Bank bought a new stake in shares of Waters in the third quarter valued at $33,000. Ashton Thomas Securities LLC purchased a new position in shares of Waters in the third quarter valued at $35,000. Itau Unibanco Holding S.A. bought a new stake in shares of Waters during the 2nd quarter valued at $33,000. Blue Trust Inc. boosted its stake in Waters by 190.2% in the 2nd quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 78 shares during the period. Finally, TFC Financial Management Inc. grew its holdings in Waters by 19,900.0% during the 2nd quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier’s stock valued at $58,000 after buying an additional 199 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on WAT shares. TD Cowen increased their price target on shares of Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Evercore ISI boosted their price target on shares of Waters from $335.00 to $355.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. The Goldman Sachs Group raised Waters to a “hold” rating in a report on Wednesday, July 31st. Sanford C. Bernstein lifted their price objective on shares of Waters from $345.00 to $360.00 and gave the stock a “market perform” rating in a report on Monday, November 4th. Finally, Barclays increased their target price on Waters from $330.00 to $360.00 and gave the company an “underweight” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Waters presently has an average rating of “Hold” and an average price target of $365.85.

Waters Stock Down 4.0 %

Shares of NYSE WAT traded down $15.06 on Friday, reaching $361.66. 188,895 shares of the company’s stock traded hands, compared to its average volume of 431,246. Waters Co. has a 12 month low of $258.89 and a 12 month high of $393.38. The business’s 50 day simple moving average is $350.16 and its two-hundred day simple moving average is $330.13. The company has a market cap of $21.48 billion, a price-to-earnings ratio of 35.95, a price-to-earnings-growth ratio of 7.05 and a beta of 0.97. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14.

Waters (NYSE:WAT) last announced its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share for the quarter, beating analysts’ consensus estimates of $2.68 by $0.25. Waters had a net margin of 21.43% and a return on equity of 49.93%. The business had revenue of $740.30 million during the quarter, compared to the consensus estimate of $712.99 million. During the same quarter last year, the firm earned $2.84 earnings per share. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. As a group, equities research analysts forecast that Waters Co. will post 11.79 EPS for the current fiscal year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.